Episode 295: PREMIUM – Taking a run at the SPRINT trial
In episode 295, Mike and James discuss the latest blood pressure target trial in an impressive PREMIUM way. We also discuss the most recent meta-analysis that looked at all of the studies (except SPRINT) that have evaluated intensive blood pressure lowering. At the end we put the entire process into a perfect perspective that some have called earth shattering; and you can only find out what we think by becoming a PREMIUM member.
1) The SPRINT trial
2) Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis